TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
3 RESEARCH METHODOLOGY
3.1 OVERVIEW
3.2 DATA FLOW
3.2.1 DATA MINING PROCESS
3.3 PURCHASED DATABASE:
3.4 SECONDARY SOURCES:
3.4.1 SECONDARY RESEARCH DATA FLOW:
3.5 PRIMARY RESEARCH:
3.5.1 PRIMARY RESEARCH DATA FLOW:
3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
3.6.1 REVENUE ANALYSIS APPROACH
3.7 DATA FORECASTING
3.7.1 DATA FORECASTING TYPE
3.8 DATA MODELING
3.8.1 MICROECONOMIC FACTOR ANALYSIS:
3.8.2 DATA MODELING:
3.9 TEAMS AND ANALYST CONTRIBUTION
4 MARKET DYNAMICS
4.1 INTRODUCTION
4.2 DRIVERS
4.2.1 GROWING PREVALENCE OF ACNE ACROSS THE GLOBE
4.2.2 TOPICAL TREATMENTS GAINING POPULARITY
4.2.3 INCREASING PRODUCT LAUNCH APPROVAL
4.3 RESTRAINTS
4.3.1 VOLUNTARY PRODUCT RECALL BY MARKET PLAYERS
4.3.2 STRINGENT REGULATORY POLICIES
4.3.3 SIDE EFFECTS AND SAFETY CONCERNS
4.4 OPPORTUNITY
4.4.1 GROWTH IN E-COMMERCE AND ONLINE PHARMACIES
4.4.2 INCREASING FUNDING AND INVESTMENT BY ACNE TREATMENT PRODUCTS MANUFACTURER
4.4.3 INCREASING DISPOSABLE INCOME CREATES OPPORTUNITIES
5 MARKET FACTOR ANALYSIS
5.1 PORTER'S FIVE FORCES MODEL
5.1.1 THREAT OF NEW ENTRANTS
5.1.2 BARGAINING POWER OF SUPPLIERS
5.1.3 THREAT OF SUBSTITUTES
5.1.4 BARGAINING POWER OF BUYERS
5.1.5 INTENSITY OF RIVALRY
5.2 IMPACT OF COVID-19 ON GLOBAL ACNE TREATMENT MARKET
5.3 NEW PRODUCT LAUNCHES
5.4 MARKET TRENDS
5.4.1 INNOVATIVE FORMULATION
5.4.2 INCREASED FOCUS ON COMBINATION THERAPIES
5.4.3 GROWTH OF TELEDERMATOLOGY PLATFORMS AND SERVICES
5.5 PIPELINE ANALYSIS
5.6 OVERVIEW ON VACCINE DEVELOPMENT AGAINST ACNE
6 GLOBAL ACNE TREATMENT MARKET, BY THERAPEUTIC TYPE
6.1 OVERVIEW
6.2 ORAL
6.2.1 ANTIBIOTICS
6.2.2 CONTRACEPTIVES
6.2.3 RETINOIDS
6.2.4 HORMONAL
6.3 TOPICAL
6.3.1 ANTIBIOTICS
6.3.2 RETINOIDS
6.3.3 BENZOYL PEROXIDE
6.3.4 SALICYLIC ACID
6.3.5 AZELAIC ACID
6.3.6 OTHERS
6.4 SYSTEMIC
6.4.1 ANTIBIOTICS
6.4.2 INTRALESIONAL STEROID INJECTIONS
7 GLOBAL ACNE TREATMENT MARKET, BY PRESCRIPTION TYPE
7.1 OVERVIEW
7.2 PRESCRIPTION-BASED
7.3 OVER-THE-COUNTER (NON-PRESCRIPTION-BASED)
8 GLOBAL ACNE TREATMENT MARKET, BY PRESCRIPTION TYPE
8.1 OVERVIEW
8.2 LOW
8.3 MODERATE
8.4 HIGH
9 GLOBAL ACNE TREATMENT MARKET, BY GENDER
9.1 OVERVIEW
9.2 MALE
9.3 FEMALE
10 GLOBAL ACNE TREATMENT MARKET, BY DISTRIBUTION CHANNEL
10.1 OVERVIEW
10.2 HOSPITAL PHARMACIES
10.3 RETAIL PHARMACIES
10.4 ONLINE
11 GLOBAL ACNE TREATMENT MARKET, BY REGION
11.1 OVERVIEW
11.2 NORTH AMERICA
11.2.1 US
11.2.2 CANADA
11.3 EUROPE
11.3.1 GERMANY
11.3.2 FRANCE
11.3.3 UK
11.3.4 SPAIN
11.3.5 ITALY
11.3.6 RUSSIA
11.3.7 REST OF EUROPE
11.4 ASIA PACIFIC
11.4.1 CHINA
11.4.2 INDIA
11.4.3 JAPAN
11.4.4 SOUTH KOREA
11.4.5 MALAYSIA
11.4.6 THAILAND
11.4.7 INDONESIA
11.4.8 REST OF ASIA PACIFIC
11.5 SOUTH AMERICA
11.5.1 BRAZIL
11.5.2 MEXICO
11.5.3 ARGENTINA
11.5.4 REST OF SOUTH AMERICA
11.6 MIDDLE EAST & AFRICA
11.6.1 GCC COUNTRIES
11.6.2 SOUTH AFRICA
11.6.3 REST OF MEA
12 COMPETITIVE LANDSCAPE
12.1 INTRODUCTION
12.2 MARKET SHARE ANALYSIS, 2024
12.3 COMPETITOR DASHBOARD
12.5 PUBLIC PLAYERS STOCK SUMMARY
12.6 COMPARATIVE ANALYSIS: KEY PLAYERS FINANCIAL
12.7 KEY DEVELOPMENTS & GROWTH STRATEGIES
12.7.1 PRODUCT LAUNCH
12.7.2 PRODUCT APPROVAL
12.7.3 AGREEMENT
12.7.4 PRODUCT EXPANSION
13 COMPANY PROFILE
13.1 PFIZER INC.
13.1.1 COMPANY OVERVIEW
13.1.2 FINANCIAL OVERVIEW
13.1.3 PRODUCTS OFFERED
13.1.4 KEY DEVELOPMENTS
13.1.5 SWOT ANALYSIS
13.1.6 KEY STRATEGIES
13.2 ABBVIE INC.
13.2.1 COMPANY OVERVIEW
13.2.2 FINANCIAL OVERVIEW
13.2.3 PRODUCTS OFFERED
13.2.4 KEY DEVELOPMENTS
13.2.5 SWOT ANALYSIS
13.2.6 KEY STRATEGIES
13.3 BAUSCH HEALTH COMPANIES INC.
13.3.1 COMPANY OVERVIEW
13.3.2 FINANCIAL OVERVIEW
13.3.3 PRODUCTS OFFERED
13.3.4 KEY DEVELOPMENTS
13.3.5 KEY STRATEGIES
13.4 GALDERMA
13.4.1 COMPANY OVERVIEW
13.4.2 FINANCIAL OVERVIEW
13.4.3 PRODUCTS OFFERED
13.4.4 KEY DEVELOPMENTS
13.4.5 KEY STRATEGIES
13.5 MAYNE PHARMA
13.5.1 COMPANY OVERVIEW
13.5.2 FINANCIAL OVERVIEW
13.5.3 PRODUCTS OFFERED
13.5.4 KEY DEVELOPMENTS
13.5.5 KEY STRATEGIES
13.6 COSETTE PHARMACEUTICALS
13.6.1 COMPANY OVERVIEW
13.6.2 FINANCIAL OVERVIEW
13.6.3 PRODUCTS OFFERED
13.6.4 KEY DEVELOPMENTS
13.6.5 KEY STRATEGIES
13.7 . JOHNSON & JOHNSON INC.
13.7.1 COMPANY OVERVIEW
13.7.2 FINANCIAL OVERVIEW
13.7.3 PRODUCTS OFFERED
13.7.4 KEY DEVELOPMENTS
SWOT ANALYSIS
13.7.5 KEY STRATEGIES
13.8 SUN PHARMACEUTICAL INDUSTRIES LTD.
13.8.1 COMPANY OVERVIEW
13.8.2 FINANCIAL OVERVIEW
13.8.3 PRODUCTS OFFERED
13.8.4 KEY DEVELOPMENTS
13.8.5 SWOT ANALYSIS
13.8.6 KEY STRATEGIES
13.9 F. HOFFMANN-LA ROCHE LTD.
13.9.1 COMPANY OVERVIEW
13.9.2 FINANCIAL OVERVIEW
13.9.3 PRODUCTS OFFERED
13.9.4 KEY DEVELOPMENTS
13.9.5 SWOT ANALYSIS
13.9.6 KEY STRATEGIES
13.10 GSK PLC
13.10.1 COMPANY OVERVIEW
13.10.2 FINANCIAL OVERVIEW
13.10.3 PRODUCT OFFERED
13.10.4 KEY DEVELOPMENTS
13.10.5 KEY STRATEGIES
13.11 TEVA PHARMACEUTICAL INDUSTRIES LTD.
13.11.1 COMPANY OVERVIEW
13.11.2 FINANCIAL OVERVIEW
13.11.3 PRODUCTS OFFERED
13.11.4 KEY DEVELOPMENTS
13.11.5 KEY STRATEGIES
13.12 CIPLA INC.
13.12.1 COMPANY OVERVIEW
13.12.2 FINANCIAL OVERVIEW
13.12.3 PRODUCTS OFFERED
13.12.4 KEY DEVELOPMENTS
13.12.5 KEY STRATEGIES
DATA CITATIONS
LIST OF TABLES
TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
TABLE 2 GLOBAL ACNE TREATMENT MARKET, BY THERAPEUTIC TYPE, 2019–2035 (USD MILLION)
TABLE 3 GLOBAL ACNE TREATMENT MARKET, FOR ORAL, BY REGION, 2019–2035 (USD MILLION)
TABLE 4 GLOBAL ACNE TREATMENT MARKET, FOR ORAL, BY TYPE, 2019–2035 (USD MILLION)
TABLE 5 GLOBAL ACNE TREATMENT MARKET, FOR ANTIBIOTIC, BY REGION, 2019–2035 (USD MILLION)
TABLE 6 GLOBAL ACNE TREATMENT MARKET, FOR ANTIBIOTICS, BY TYPE, 2019–2035 (USD MILLION)
TABLE 7 GLOBAL ACNE TREATMENT MARKET, FOR CONTRACEPTIVES, BY REGION, 2019–2035 (USD MILLION)
TABLE 8 GLOBAL ACNE TREATMENT MARKET, FOR RETINOIDS, BY REGION, 2019–2035 (USD MILLION)
TABLE 9 GLOBAL ACNE TREATMENT MARKET, FOR RETINOIDS, BY TYPE, 2019–2035 (USD MILLION)
TABLE 10 GLOBAL ACNE TREATMENT MARKET, FOR HORMONAL, BY REGION, 2019–2035 (USD MILLION)
TABLE 11 GLOBAL ACNE TREATMENT MARKET, FOR TOPICAL, BY REGION, 2019–2035 (USD MILLION)
TABLE 12 GLOBAL ACNE TREATMENT MARKET, FOR TOPICAL, BY TYPE, 2019–2035 (USD MILLION)
TABLE 13 GLOBAL ACNE TREATMENT MARKET, FOR ANTIBIOTIC, BY REGION, 2019–2035 (USD MILLION)
TABLE 14 GLOBAL ACNE TREATMENT MARKET, FOR ANTIBIOTICS, BY TYPE, 2019–2035 (USD MILLION)
TABLE 15 GLOBAL ACNE TREATMENT MARKET, FOR RETINOIDS, BY REGION, 2019–2035 (USD MILLION)
TABLE 16 GLOBAL ACNE TREATMENT MARKET, FOR RETINOIDS, BY TYPE, 2019–2035 (USD MILLION)
TABLE 17 GLOBAL ACNE TREATMENT MARKET, FOR BENZOYL PEROXIDE, BY REGION, 2019–2035 (USD MILLION)
TABLE 18 GLOBAL ACNE TREATMENT MARKET, FOR SALICYLIC ACID, BY REGION, 2019–2035 (USD MILLION)
TABLE 19 GLOBAL ACNE TREATMENT MARKET, FOR AZELAIC ACID, BY REGION, 2019–2035 (USD MILLION)
TABLE 20 GLOBAL ACNE TREATMENT MARKET, FOR OTHERS, BY REGION, 2019–2035 (USD MILLION)
TABLE 21 GLOBAL ACNE TREATMENT MARKET, FOR SYSTEMIC, BY REGION, 2019–2035 (USD MILLION)
TABLE 22 GLOBAL ACNE TREATMENT MARKET, FOR SYSTEMIC, BY TYPE, 2019–2035 (USD MILLION)
TABLE 23 GLOBAL ACNE TREATMENT MARKET, FOR ANTIBIOTICS, BY REGION, 2019–2035 (USD MILLION)
TABLE 24 GLOBAL ACNE TREATMENT MARKET, FOR INTRALESIONAL STEROID INJECTIONS, BY REGION, 2019–2035 (USD MILLION)
TABLE 25 GLOBAL ACNE TREATMENT MARKET, BY PRESCRIPTION TYPE, 2019–2035 (USD MILLION)
TABLE 26 GLOBAL ACNE TREATMENT MARKET, FOR PRESCRIPTION-BASED, BY REGION, 2019–2035 (USD MILLION)
TABLE 27 GLOBAL ACNE TREATMENT MARKET, FOR OVER-THE-COUNTER (NON-PRESCRIPTION-BASED), BY REGION, 2019–2035 (USD MILLION)
TABLE 28 GLOBAL ACNE TREATMENT MARKET, BY ACNE SEVERITY, 2019–2035 (USD MILLION)
TABLE 29 GLOBAL ACNE TREATMENT MARKET, FOR LOW, BY REGION, 2019–2035 (USD MILLION)
TABLE 30 GLOBAL ACNE TREATMENT MARKET, FOR MODERATE, BY REGION, 2019–2035 (USD MILLION)
TABLE 31 GLOBAL ACNE TREATMENT MARKET, FOR HIGH, BY REGION, 2019–2035 (USD MILLION)
TABLE 32 GLOBAL ACNE TREATMENT MARKET, BY GENDER, 2019–2035 (USD MILLION)
TABLE 33 GLOBAL ACNE TREATMENT MARKET, FOR MALE, BY REGION, 2019–2035 (USD MILLION)
TABLE 34 GLOBAL ACNE TREATMENT MARKET, FOR FEMALE, BY REGION, 2019–2035 (USD MILLION)
TABLE 35 GLOBAL ACNE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD MILLION)
TABLE 36 GLOBAL ACNE TREATMENT MARKET, FOR HOSPITAL PHARMACIES, BY REGION, 2019–2035 (USD MILLION)
TABLE 37 GLOBAL ACNE TREATMENT MARKET, FOR RETAIL PHARMACIES, BY REGION, 2019–2035 (USD MILLION)
TABLE 38 GLOBAL ACNE TREATMENT MARKET, FOR ONLINE, BY REGION, 2019–2035 (USD MILLION)
TABLE 39 GLOBAL ACNE TREATMENT MARKET, BY REGION, 2019–2035 (USD MILLION)
TABLE 40 NORTH AMERICA ACNE TREATMENT MARKET, BY COUNTRY, 2019–2035 (USD MILLION)
TABLE 41 NORTH AMERICA ACNE TREATMENT MARKET, BY THERAPEUTIC TYPE, 2019–2035 (USD MILLION)
TABLE 42 NORTH AMERICA ACNE TREATMENT MARKET, FOR ORAL, BY TYPE, 2019–2035 (USD MILLION)
TABLE 43 NORTH AMERICA ACNE TREATMENT MARKET, FOR ANTIBIOTICS, BY TYPE, 2019–2035 (USD MILLION)
TABLE 44 NORTH AMERICA ACNE TREATMENT MARKET, FOR RETENOIDS, BY TYPE, 2019–2035 (USD MILLION)
TABLE 45 NORTH AMERICA ACNE TREATMENT MARKET, FOR TOPICAL, BY TYPE, 2019–2035 (USD MILLION)
TABLE 46 NORTH AMERICA ACNE TREATMENT MARKET, FOR ANTIBIOTICS, BY TYPE, 2019–2035 (USD MILLION)
TABLE 47 NORTH AMERICA ACNE TREATMENT MARKET, FOR RETINOIDS, BY TYPE, 2019–2035 (USD MILLION)
TABLE 48 NORTH AMERICA ACNE TREATMENT MARKET, FOR SYSTEMIC, BY TYPE, 2019–2035 (USD MILLION)
TABLE 49 NORTH AMERICA ACNE TREATMENT MARKET, BY PRESCRIPTION TYPE, 2019–2035 (USD MILLION)
TABLE 50 NORTH AMERICA ACNE TREATMENT MARKET, BY ACNE SEVERITY, 2019–2035 (USD MILLION)
TABLE 51 NORTH AMERICA ACNE TREATMENT MARKET, BY GENDER, 2019–2035 (USD MILLION)
TABLE 52 NORTH AMERICA ACNE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD MILLION)
TABLE 53 US: ACNE TREATMENT MARKET, BY THERAPEUTIC TYPE, 2019–2035 (USD MILLION)
TABLE 54 US: ACNE TREATMENT MARKET, FOR ORAL, BY TYPE, 2019–2035 (USD MILLION)
TABLE 55 US: ACNE TREATMENT MARKET, FOR ANTIBIOTICS, BY TYPE, 2019–2035 (USD MILLION)
TABLE 56 US: ACNE TREATMENT MARKET, FOR RETENOIDS, BY TYPE, 2019–2035 (USD MILLION)
TABLE 57 US: ACNE TREATMENT MARKET, FOR TOPICAL, BY TYPE, 2019–2035 (USD MILLION)
TABLE 58 US: ACNE TREATMENT MARKET, FOR ANTIBIOTICS, BY TYPE, 2019–2035 (USD MILLION)
TABLE 59 US: ACNE TREATMENT MARKET, FOR RETINOIDS, BY TYPE, 2019–2035 (USD MILLION)
TABLE 60 US: ACNE TREATMENT MARKET, FOR SYSTEMIC, BY TYPE, 2019–2035 (USD MILLION)
TABLE 61 US: ACNE TREATMENT MARKET, BY PRESCRIPTION TYPE, 2019–2035 (USD MILLION)
TABLE 62 US: ACNE TREATMENT MARKET, BY ACNE SEVERITY, 2019–2035 (USD MILLION)
TABLE 63 US: ACNE TREATMENT MARKET, BY GENDER, 2019–2035 (USD MILLION)
TABLE 64 US: ACNE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD MILLION)
TABLE 65 CANADA: ACNE TREATMENT MARKET, BY THERAPEUTIC TYPE, 2019–2035 (USD MILLION)
TABLE 66 CANADA: ACNE TREATMENT MARKET, FOR ORAL, BY TYPE, 2019–2035 (USD MILLION)
TABLE 67 CANADA: ACNE TREATMENT MARKET, FOR ANTIBIOTICS, BY TYPE, 2019–2035 (USD MILLION)
TABLE 68 CANADA: ACNE TREATMENT MARKET, FOR RETENOIDS, BY TYPE, 2019–2035 (USD MILLION)
TABLE 69 CANADA: ACNE TREATMENT MARKET, FOR TOPICAL, BY TYPE, 2019–2035 (USD MILLION)
TABLE 70 CANADA: ACNE TREATMENT MARKET, FOR ANTIBIOTICS, BY TYPE, 2019–2035 (USD MILLION)
TABLE 71 CANADA: ACNE TREATMENT MARKET, FOR RETINOIDS, BY TYPE, 2019–2035 (USD MILLION)
TABLE 72 CANADA: ACNE TREATMENT MARKET, FOR SYSTEMIC, BY TYPE, 2019–2035 (USD MILLION)
TABLE 73 CANADA: ACNE TREATMENT MARKET, BY PRESCRIPTION TYPE, 2019–2035 (USD MILLION)
TABLE 74 CANADA: ACNE TREATMENT MARKET, BY ACNE SEVERITY, 2019–2035 (USD MILLION)
TABLE 75 CANADA: ACNE TREATMENT MARKET, BY GENDER, 2019–2035 (USD MILLION)
TABLE 76 CANADA: ACNE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD MILLION)
TABLE 77 EUROPE ACNE TREATMENT MARKET, BY COUNTRY, 2019–2035 (USD MILLION)
TABLE 78 EUROPE ACNE TREATMENT MARKET, BY THERAPEUTIC TYPE, 2019–2035 (USD MILLION)
TABLE 79 EUROPE ACNE TREATMENT MARKET, FOR ORAL, BY TYPE, 2019–2035 (USD MILLION)
TABLE 80 EUROPE ACNE TREATMENT MARKET, FOR ANTIBIOTICS, BY TYPE, 2019–2035 (USD MILLION)
TABLE 81 EUROPE ACNE TREATMENT MARKET, FOR RETENOIDS, BY TYPE, 2019–2035 (USD MILLION)
TABLE 82 EUROPE ACNE TREATMENT MARKET, FOR TOPICAL, BY TYPE, 2019–2035 (USD MILLION)
TABLE 83 EUROPE ACNE TREATMENT MARKET, FOR ANTIBIOTICS, BY TYPE, 2019–2035 (USD MILLION)
TABLE 84 EUROPE ACNE TREATMENT MARKET, FOR RETINOIDS, BY TYPE, 2019–2035 (USD MILLION)
TABLE 85 EUROPE ACNE TREATMENT MARKET, FOR SYSTEMIC, BY TYPE, 2019–2035 (USD MILLION)
TABLE 86 EUROPE ACNE TREATMENT MARKET, BY PRESCRIPTION TYPE, 2019–2035 (USD MILLION)
TABLE 87 EUROPE ACNE TREATMENT MARKET, BY ACNE SEVERITY, 2019–2035 (USD MILLION)
TABLE 88 EUROPE ACNE TREATMENT MARKET, BY GENDER, 2019–2035 (USD MILLION)
TABLE 89 EUROPE ACNE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD MILLION)
TABLE 90 GERMANY ACNE TREATMENT MARKET, BY THERAPEUTIC TYPE, 2019–2035 (USD MILLION)
TABLE 91 GERMANY ACNE TREATMENT MARKET, FOR ORAL, BY TYPE, 2019–2035 (USD MILLION)
TABLE 92 GERMANY ACNE TREATMENT MARKET, FOR ANTIBIOTICS, BY TYPE, 2019–2035 (USD MILLION)
TABLE 93 GERMANY ACNE TREATMENT MARKET, FOR RETENOIDS, BY TYPE, 2019–2035 (USD MILLION)
TABLE 94 GERMANY ACNE TREATMENT MARKET, FOR TOPICAL, BY TYPE, 2019–2035 (USD MILLION)
TABLE 95 GERMANY ACNE TREATMENT MARKET, FOR ANTIBIOTICS, BY TYPE, 2019–2035 (USD MILLION)
TABLE 96 GERMANY ACNE TREATMENT MARKET, FOR RETINOIDS, BY TYPE, 2019–2035 (USD MILLION)
TABLE 97 GERMANY ACNE TREATMENT MARKET, FOR SYSTEMIC, BY TYPE, 2019–2035 (USD MILLION)
TABLE 98 GERMANY ACNE TREATMENT MARKET, BY PRESCRIPTION TYPE, 2019–2035 (USD MILLION)
TABLE 99 GERMANY ACNE TREATMENT MARKET, BY ACNE SEVERITY, 2019–2035 (USD MILLION)
TABLE 100 GERMANY ACNE TREATMENT MARKET, BY GENDER, 2019–2035 (USD MILLION)
TABLE 101 GERMANY ACNE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD MILLION)
TABLE 102 FRANCE ACNE TREATMENT MARKET, BY THERAPEUTIC TYPE, 2019–2035 (USD MILLION)
TABLE 103 FRANCE ACNE TREATMENT MARKET, FOR ORAL, BY TYPE, 2019–2035 (USD MILLION)
TABLE 104 FRANCE ACNE TREATMENT MARKET, FOR ANTIBIOTICS, BY TYPE, 2019–2035 (USD MILLION)
TABLE 105 FRANCE ACNE TREATMENT MARKET, FOR RETENOIDS, BY TYPE, 2019–2035 (USD MILLION)
TABLE 106 FRANCE ACNE TREATMENT MARKET, FOR TOPICAL, BY TYPE, 2019–2035 (USD MILLION)
TABLE 107 FRANCE ACNE TREATMENT MARKET, FOR ANTIBIOTICS, BY TYPE, 2019–2035 (USD MILLION)
TABLE 108 FRANCE ACNE TREATMENT MARKET, FOR RETINOIDS, BY TYPE, 2019–2035 (USD MILLION)
TABLE 109 FRANCE ACNE TREATMENT MARKET, FOR SYSTEMIC, BY TYPE, 2019–2035 (USD MILLION)
TABLE 110 FRANCE ACNE TREATMENT MARKET, BY PRESCRIPTION TYPE, 2019–2035 (USD MILLION)
TABLE 111 FRANCE ACNE TREATMENT MARKET, BY ACNE SEVERITY, 2019–2035 (USD MILLION)
TABLE 112 FRANCE ACNE TREATMENT MARKET, BY GENDER, 2019–2035 (USD MILLION)
TABLE 113 FRANCE ACNE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD MILLION)
TABLE 114 UK ACNE TREATMENT MARKET, BY THERAPEUTIC TYPE, 2019–2035 (USD MILLION)
TABLE 115 UK ACNE TREATMENT MARKET, FOR ORAL, BY TYPE, 2019–2035 (USD MILLION)
TABLE 116 UK ACNE TREATMENT MARKET, FOR ANTIBIOTICS, BY TYPE, 2019–2035 (USD MILLION)
TABLE 117 UK ACNE TREATMENT MARKET, FOR RETENOIDS, BY TYPE, 2019–2035 (USD MILLION)
TABLE 118 UK ACNE TREATMENT MARKET, FOR TOPICAL, BY TYPE, 2019–2035 (USD MILLION)
TABLE 119 UK ACNE TREATMENT MARKET, FOR ANTIBIOTICS, BY TYPE, 2019–2035 (USD MILLION)
TABLE 120 UK ACNE TREATMENT MARKET, FOR RETINOIDS, BY TYPE, 2019–2035 (USD MILLION)
TABLE 121 UK ACNE TREATMENT MARKET, FOR SYSTEMIC, BY TYPE, 2019–2035 (USD MILLION)
TABLE 122 UK ACNE TREATMENT MARKET, BY PRESCRIPTION TYPE, 2019–2035 (USD MILLION)
TABLE 123 UK ACNE TREATMENT MARKET, BY ACNE SEVERITY, 2019–2035 (USD MILLION)
TABLE 124 UK ACNE TREATMENT MARKET, BY GENDER, 2019–2035 (USD MILLION)
TABLE 125 UK ACNE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD MILLION)
TABLE 126 SPAIN ACNE TREATMENT MARKET, BY THERAPEUTIC TYPE, 2019–2035 (USD MILLION)
TABLE 127 SPAIN ACNE TREATMENT MARKET, FOR ORAL, BY TYPE, 2019–2035 (USD MILLION)
TABLE 128 SPAIN ACNE TREATMENT MARKET, FOR ANTIBIOTICS, BY TYPE, 2019–2035 (USD MILLION)
TABLE 129 SPAIN ACNE TREATMENT MARKET, FOR RETENOIDS, BY TYPE, 2019–2035 (USD MILLION)
TABLE 130 SPAIN ACNE TREATMENT MARKET, FOR TOPICAL, BY TYPE, 2019–2035 (USD MILLION)
TABLE 131 SPAIN ACNE TREATMENT MARKET, FOR ANTIBIOTICS, BY TYPE, 2019–2035 (USD MILLION)
TABLE 132 SPAIN ACNE TREATMENT MARKET, FOR RETINOIDS, BY TYPE, 2019–2035 (USD MILLION)
TABLE 133 SPAIN ACNE TREATMENT MARKET, FOR SYSTEMIC, BY TYPE, 2019–2035 (USD MILLION)
TABLE 134 SPAIN ACNE TREATMENT MARKET, BY PRESCRIPTION TYPE, 2019–2035 (USD MILLION)
TABLE 135 SPAIN ACNE TREATMENT MARKET, BY ACNE SEVERITY, 2019–2035 (USD MILLION)
TABLE 136 SPAIN ACNE TREATMENT MARKET, BY GENDER, 2019–2035 (USD MILLION)
TABLE 137 SPAIN ACNE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD MILLION)
TABLE 138 ITALY ACNE TREATMENT MARKET, BY THERAPEUTIC TYPE, 2019–2035 (USD MILLION)
TABLE 139 ITALY ACNE TREATMENT MARKET, FOR ORAL, BY TYPE, 2019–2035 (USD MILLION)
TABLE 140 ITALY ACNE TREATMENT MARKET, FOR ANTIBIOTICS, BY TYPE, 2019–2035 (USD MILLION)
TABLE 141 ITALY ACNE TREATMENT MARKET, FOR RETENOIDS, BY TYPE, 2019–2035 (USD MILLION)
TABLE 142 ITALY ACNE TREATMENT MARKET, FOR TOPICAL, BY TYPE, 2019–2035 (USD MILLION)
TABLE 143 ITALY ACNE TREATMENT MARKET, FOR ANTIBIOTICS, BY TYPE, 2019–2035 (USD MILLION)
TABLE 144 ITALY ACNE TREATMENT MARKET, FOR RETINOIDS, BY TYPE, 2019–2035 (USD MILLION)
TABLE 145 ITALY ACNE TREATMENT MARKET, FOR SYSTEMIC, BY TYPE, 2019–2035 (USD MILLION)
TABLE 146 ITALY ACNE TREATMENT MARKET, BY PRESCRIPTION TYPE, 2019–2035 (USD MILLION)
TABLE 147 ITALY ACNE TREATMENT MARKET, BY ACNE SEVERITY, 2019–2035 (USD MILLION)
TABLE 148 ITALY ACNE TREATMENT MARKET, BY GENDER, 2019–2035 (USD MILLION)
TABLE 149 ITALY ACNE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD MILLION)
TABLE 150 RUSSIA ACNE TREATMENT MARKET, BY THERAPEUTIC TYPE, 2019–2035 (USD MILLION)
TABLE 151 RUSSIA ACNE TREATMENT MARKET, FOR ORAL, BY TYPE, 2019–2035 (USD MILLION)
TABLE 152 RUSSIA ACNE TREATMENT MARKET, FOR ANTIBIOTICS, BY TYPE, 2019–2035 (USD MILLION)
TABLE 153 RUSSIA ACNE TREATMENT MARKET, FOR RETENOIDS, BY TYPE, 2019–2035 (USD MILLION)
TABLE 154 RUSSIA ACNE TREATMENT MARKET, FOR TOPICAL, BY TYPE, 2019–2035 (USD MILLION)
TABLE 155 RUSSIA ACNE TREATMENT MARKET, FOR ANTIBIOTICS, BY TYPE, 2019–2035 (USD MILLION)
TABLE 156 RUSSIA ACNE TREATMENT MARKET, FOR RETINOIDS, BY TYPE, 2019–2035 (USD MILLION)
TABLE 157 RUSSIA ACNE TREATMENT MARKET, FOR SYSTEMIC, BY TYPE, 2019–2035 (USD MILLION)
TABLE 158 RUSSIA ACNE TREATMENT MARKET, BY PRESCRIPTION TYPE, 2019–2035 (USD MILLION)
TABLE 159 RUSSIA ACNE TREATMENT MARKET, BY ACNE SEVERITY, 2019–2035 (USD MILLION)
TABLE 160 RUSSIA ACNE TREATMENT MARKET, BY GENDER, 2019–2035 (USD MILLION)
TABLE 161 RUSSIA ACNE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD MILLION)
TABLE 162 REST OF EUROPE ACNE TREATMENT MARKET, BY THERAPEUTIC TYPE, 2019–2035 (USD MILLION)
TABLE 163 REST OF EUROPE ACNE TREATMENT MARKET, FOR ORAL, BY TYPE, 2019–2035 (USD MILLION)
TABLE 164 REST OF EUROPE ACNE TREATMENT MARKET, FOR ANTIBIOTICS, BY TYPE, 2019–2035 (USD MILLION)
TABLE 165 REST OF EUROPE ACNE TREATMENT MARKET, FOR RETENOIDS, BY TYPE, 2019–2035 (USD MILLION)
TABLE 166 REST OF EUROPE ACNE TREATMENT MARKET, FOR TOPICAL, BY TYPE, 2019–2035 (USD MILLION)
TABLE 167 REST OF EUROPE ACNE TREATMENT MARKET, FOR ANTIBIOTICS, BY TYPE, 2019–2035 (USD MILLION)
TABLE 168 REST OF EUROPE ACNE TREATMENT MARKET, FOR RETINOIDS, BY TYPE, 2019–2035 (USD MILLION)
TABLE 169 REST OF EUROPE ACNE TREATMENT MARKET, FOR SYSTEMIC, BY TYPE, 2019–2035 (USD MILLION)
TABLE 170 REST OF EUROPE ACNE TREATMENT MARKET, BY PRESCRIPTION TYPE, 2019–2035 (USD MILLION)
TABLE 171 REST OF EUROPE ACNE TREATMENT MARKET, BY ACNE SEVERITY, 2019–2035 (USD MILLION)
TABLE 172 REST OF EUROPE ACNE TREATMENT MARKET, BY GENDER, 2019–2035 (USD MILLION)
TABLE 173 REST OF EUROPE ACNE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019–2035 (USD MILLION)
TABLE 174 ASIA PACIFIC: ACNE TREATMENT MARKET, BY COUNTRY, 2019-2035 (USD MILLION)
TABLE 175 ASIA PACIFIC: ACNE TREATMENT MARKET, BY THERAPEUTIC TYPE, 2019-2035 (USD MILLION)
TABLE 176 ASIA PACIFIC: ACNE TREATMENT MARKET, FOR ORAL, BY TYPE, 2019-2035 (USD MILLION)
TABLE 177 ASIA PACIFIC: ACNE TREATMENT MARKET, FOR ANTIBIOTICS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 178 ASIA PACIFIC: ACNE TREATMENT MARKET, FOR RETINOIDS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 179 ASIA PACIFIC: ACNE TREATMENT MARKET, FOR TOPICAL, BY TYPE, 2019-2035 (USD MILLION)
TABLE 180 ASIA PACIFIC: ACNE TREATMENT MARKET, FOR ANTIBIOTICS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 181 ASIA PACIFIC: ACNE TREATMENT MARKET, FOR RETINOIDS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 182 ASIA PACIFIC: ACNE TREATMENT MARKET, FOR SYSTEMIC, BY TYPE, 2019-2035 (USD MILLION)
TABLE 183 ASIA PACIFIC: ACNE TREATMENT MARKET, BY PRESCRIPTION TYPE, 2019-2035 (USD MILLION)
TABLE 184 ASIA PACIFIC: ACNE TREATMENT MARKET, BY ACNE SEVERITY, 2019-2035 (USD MILLION)
TABLE 185 ASIA PACIFIC: ACNE TREATMENT MARKET, BY GENDER, 2019-2035 (USD MILLION)
TABLE 186 ASIA PACIFIC: ACNE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
TABLE 187 CHINA: ACNE TREATMENT MARKET, BY THERAPEUTIC TYPE, 2019-2035 (USD MILLION)
TABLE 188 CHINA: ACNE TREATMENT MARKET, FOR ORAL, BY TYPE, 2019-2035 (USD MILLION)
TABLE 189 CHINA: ACNE TREATMENT MARKET, FOR ANTIBIOTICS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 190 CHINA: ACNE TREATMENT MARKET, FOR RETINOIDS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 191 CHINA: ACNE TREATMENT MARKET, FOR TOPICAL, BY TYPE, 2019-2035 (USD MILLION)
TABLE 192 CHINA: ACNE TREATMENT MARKET, FOR ANTIBIOTICS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 193 CHINA: ACNE TREATMENT MARKET, FOR RETINOIDS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 194 CHINA: ACNE TREATMENT MARKET, FOR SYSTEMIC, BY TYPE, 2019-2035 (USD MILLION)
TABLE 195 CHINA: ACNE TREATMENT MARKET, BY PRESCRIPTION TYPE, 2019-2035 (USD MILLION)
TABLE 196 CHINA: ACNE TREATMENT MARKET, BY ACNE SEVERITY, 2019-2035 (USD MILLION)
TABLE 197 CHINA: ACNE TREATMENT MARKET, BY GENDER, 2019-2035 (USD MILLION)
TABLE 198 CHINA: ACNE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
TABLE 199 INDIA: ACNE TREATMENT MARKET, BY THERAPEUTIC TYPE, 2019-2035 (USD MILLION)
TABLE 200 INDIA: ACNE TREATMENT MARKET, FOR ORAL, BY TYPE, 2019-2035 (USD MILLION)
TABLE 201 INDIA: ACNE TREATMENT MARKET, FOR ANTIBIOTICS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 202 INDIA: ACNE TREATMENT MARKET, FOR RETINOIDS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 203 INDIA: ACNE TREATMENT MARKET, FOR TOPICAL, BY TYPE, 2019-2035 (USD MILLION)
TABLE 204 INDIA: ACNE TREATMENT MARKET, FOR ANTIBIOTICS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 205 INDIA: ACNE TREATMENT MARKET, FOR RETINOIDS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 206 INDIA: ACNE TREATMENT MARKET, FOR SYSTEMIC, BY TYPE, 2019-2035 (USD MILLION)
TABLE 207 INDIA: ACNE TREATMENT MARKET, BY PRESCRIPTION TYPE, 2019-2035 (USD MILLION)
TABLE 208 INDIA: ACNE TREATMENT MARKET, BY ACNE SEVERITY, 2019-2035 (USD MILLION)
TABLE 209 INDIA: ACNE TREATMENT MARKET, BY GENDER, 2019-2035 (USD MILLION)
TABLE 210 INDIA: ACNE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
TABLE 211 JAPAN: ACNE TREATMENT MARKET, BY THERAPEUTIC TYPE, 2019-2035 (USD MILLION)
TABLE 212 JAPAN: ACNE TREATMENT MARKET, FOR ORAL, BY TYPE, 2019-2035 (USD MILLION)
TABLE 213 JAPAN: ACNE TREATMENT MARKET, FOR ANTIBIOTICS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 214 JAPAN: ACNE TREATMENT MARKET, FOR RETINOIDS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 215 JAPAN: ACNE TREATMENT MARKET, FOR TOPICAL, BY TYPE, 2019-2035 (USD MILLION)
TABLE 216 JAPAN: ACNE TREATMENT MARKET, FOR ANTIBIOTICS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 217 JAPAN: ACNE TREATMENT MARKET, FOR RETINOIDS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 218 JAPAN: ACNE TREATMENT MARKET, FOR SYSTEMIC, BY TYPE, 2019-2035 (USD MILLION)
TABLE 219 JAPAN: ACNE TREATMENT MARKET, BY PRESCRIPTION TYPE, 2019-2035 (USD MILLION)
TABLE 220 JAPAN: ACNE TREATMENT MARKET, BY ACNE SEVERITY, 2019-2035 (USD MILLION)
TABLE 221 JAPAN: ACNE TREATMENT MARKET, BY GENDER, 2019-2035 (USD MILLION)
TABLE 222 JAPAN: ACNE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
TABLE 223 SOUTH KOREA: ACNE TREATMENT MARKET, BY THERAPEUTIC TYPE, 2019-2035 (USD MILLION)
TABLE 224 SOUTH KOREA: ACNE TREATMENT MARKET, FOR ORAL, BY TYPE, 2019-2035 (USD MILLION)
TABLE 225 SOUTH KOREA: ACNE TREATMENT MARKET, FOR ANTIBIOTICS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 226 SOUTH KOREA: ACNE TREATMENT MARKET, FOR RETINOIDS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 227 SOUTH KOREA: ACNE TREATMENT MARKET, FOR TOPICAL, BY TYPE, 2019-2035 (USD MILLION)
TABLE 228 SOUTH KOREA: ACNE TREATMENT MARKET, FOR ANTIBIOTICS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 229 SOUTH KOREA: ACNE TREATMENT MARKET, FOR RETINOIDS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 230 SOUTH KOREA: ACNE TREATMENT MARKET, FOR SYSTEMIC, BY TYPE, 2019-2035 (USD MILLION)
TABLE 231 SOUTH KOREA: ACNE TREATMENT MARKET, BY PRESCRIPTION TYPE, 2019-2035 (USD MILLION)
TABLE 232 SOUTH KOREA: ACNE TREATMENT MARKET, BY ACNE SEVERITY, 2019-2035 (USD MILLION)
TABLE 233 SOUTH KOREA: ACNE TREATMENT MARKET, BY GENDER, 2019-2035 (USD MILLION)
TABLE 234 SOUTH KOREA: ACNE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
TABLE 235 MALAYSIA: ACNE TREATMENT MARKET, BY THERAPEUTIC TYPE, 2019-2035 (USD MILLION)
TABLE 236 MALAYSIA: ACNE TREATMENT MARKET, FOR ORAL, BY TYPE, 2019-2035 (USD MILLION)
TABLE 237 MALAYSIA: ACNE TREATMENT MARKET, FOR ANTIBIOTICS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 238 MALAYSIA: ACNE TREATMENT MARKET, FOR RETINOIDS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 239 MALAYSIA: ACNE TREATMENT MARKET, FOR TOPICAL, BY TYPE, 2019-2035 (USD MILLION)
TABLE 240 MALAYSIA: ACNE TREATMENT MARKET, FOR ANTIBIOTICS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 241 MALAYSIA: ACNE TREATMENT MARKET, FOR RETINOIDS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 242 MALAYSIA: ACNE TREATMENT MARKET, FOR SYSTEMIC, BY TYPE, 2019-2035 (USD MILLION)
TABLE 243 MALAYSIA: ACNE TREATMENT MARKET, BY PRESCRIPTION TYPE, 2019-2035 (USD MILLION)
TABLE 244 MALAYSIA: ACNE TREATMENT MARKET, BY ACNE SEVERITY, 2019-2035 (USD MILLION)
TABLE 245 MALAYSIA: ACNE TREATMENT MARKET, BY GENDER, 2019-2035 (USD MILLION)
TABLE 246 MALAYSIA: ACNE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
TABLE 247 THAILAND: ACNE TREATMENT MARKET, BY THERAPEUTIC TYPE, 2019-2035 (USD MILLION)
TABLE 248 THAILAND: ACNE TREATMENT MARKET, FOR ORAL, BY TYPE, 2019-2035 (USD MILLION)
TABLE 249 THAILAND: ACNE TREATMENT MARKET, FOR ANTIBIOTICS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 250 THAILAND: ACNE TREATMENT MARKET, FOR RETINOIDS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 251 THAILAND: ACNE TREATMENT MARKET, FOR TOPICAL, BY TYPE, 2019-2035 (USD MILLION)
TABLE 252 THAILAND: ACNE TREATMENT MARKET, FOR ANTIBIOTICS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 253 THAILAND: ACNE TREATMENT MARKET, FOR RETINOIDS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 254 THAILAND: ACNE TREATMENT MARKET, FOR SYSTEMIC, BY TYPE, 2019-2035 (USD MILLION)
TABLE 255 THAILAND: ACNE TREATMENT MARKET, BY PRESCRIPTION TYPE, 2019-2035 (USD MILLION)
TABLE 256 THAILAND: ACNE TREATMENT MARKET, BY ACNE SEVERITY, 2019-2035 (USD MILLION)
TABLE 257 THAILAND: ACNE TREATMENT MARKET, BY GENDER, 2019-2035 (USD MILLION)
TABLE 258 THAILAND: ACNE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
TABLE 259 INDONESIA: ACNE TREATMENT MARKET, BY THERAPEUTIC TYPE, 2019-2035 (USD MILLION)
TABLE 260 INDONESIA: ACNE TREATMENT MARKET, FOR ORAL, BY TYPE, 2019-2035 (USD MILLION)
TABLE 261 INDONESIA: ACNE TREATMENT MARKET, FOR ANTIBIOTICS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 262 INDONESIA: ACNE TREATMENT MARKET, FOR RETINOIDS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 263 INDONESIA: ACNE TREATMENT MARKET, FOR TOPICAL, BY TYPE, 2019-2035 (USD MILLION)
TABLE 264 INDONESIA: ACNE TREATMENT MARKET, FOR ANTIBIOTICS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 265 INDONESIA: ACNE TREATMENT MARKET, FOR RETINOIDS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 266 INDONESIA: ACNE TREATMENT MARKET, FOR SYSTEMIC, BY TYPE, 2019-2035 (USD MILLION)
TABLE 267 INDONESIA: ACNE TREATMENT MARKET, BY PRESCRIPTION TYPE, 2019-2035 (USD MILLION)
TABLE 268 INDONESIA: ACNE TREATMENT MARKET, BY ACNE SEVERITY, 2019-2035 (USD MILLION)
TABLE 269 INDONESIA: ACNE TREATMENT MARKET, BY GENDER, 2019-2035 (USD MILLION)
TABLE 270 INDONESIA: ACNE TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2035 (USD MILLION)
TABLE 271 REST OF ASIA PACIFIC: ACNE TREATMENT MARKET, BY THERAPEUTIC TYPE, 2019-2035 (USD MILLION)
TABLE 272 REST OF ASIA PACIFIC: ACNE TREATMENT MARKET, FOR ORAL, BY TYPE, 2019-2035 (USD MILLION)
TABLE 273 REST OF ASIA PACIFIC: ACNE TREATMENT MARKET, FOR ANTIBIOTICS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 274 REST OF ASIA PACIFIC: ACNE TREATMENT MARKET, FOR RETINOIDS, BY TYPE, 2019-2035 (USD MILLION)
TABLE 275 REST OF ASIA PACIFIC: ACNE TREATMENT MARKET, FOR TOPICAL, BY TYPE, 2019-2035 (USD MILLION)
TABLE 276 REST OF ASIA PACIFIC: ACNE TREATMENT MARKET, FOR ANTIBIOTICS, BY TYPE, 2019
